Take this benchmark to assess how much you would benefit from taking the course on the Proposed Rule for the Medicare Drug Price Negotiation Program.
This quick, pre-course check is not a test of memorization. It surfaces how well you grasp the proposed rule’s intent, trade-offs, and operational impacts—so you can decide whether a deeper dive will save you time, reduce risk, and improve decisions.
- See the value fast: Identify blind spots on policy intent (affordability vs. innovation), operational readiness (data, timelines, compliance), and equity implications for beneficiaries.
- Make smarter calls: Gauge how negotiation mechanics (MFP ceilings, combined Part B/D amounts, confidentiality) could affect pricing, access, and workflows.
- Act with confidence: Pinpoint where public comments and evidence can influence outcomes before the rule is finalized.
Use your results to decide if you should take the full course now, skim select modules, or return later.



